Advanced Balloon Catheter Market worth USD 5,381.1 million by 2030

The Market Statsville Group (MSG) publishes the new report on the "Advanced Balloon Catheter Market by Product Type (Normal Balloon Catheter, Cutting and Scoring Balloon Catheter, Drug-Coated Balloon Catheter, and Stent-Graft Balloon Catheter), by Component (Over the Wire Balloon Catheter, Rapid Exchange (Rx) Balloon Catheter, and Fixed Wire Balloon Catheter), by Patient Age (Adult and Pediatric), by End-Users (Hospitals and Ambulatory Surgery Centers, Catheterization Laboratories), by Application (Coronary Procedures, Peripheral Procedures, Neurovascular Procedures, and Other Procedures), by Region – Global Share and Forecast to 2030". The global advanced balloon catheter market size is expected to grow USD 5,381.1 million by 2030 from USD 2,893.3 million in 2021, at a CAGR of 7.1% from 2022-2030. The global healthcare system is continuously evolving to improve quality, affordability, and access to healthcare services. One of the major technological breakthroughs in the past few years is the increasing adoption of minimally invasive surgeries (MIS)in comparison to conventional surgical methods. The less recovery time, reduced risk of complications, and decreased rate of hospital readmissions are the propellers for the increasing adoption of minimally invasive procedures. In CVD and PAD, the adoption of minimally invasive procedures, such as angioplasty, stenting, balloon occlusion, and drug delivery, has driven the sales of various sorts of balloon catheters.

Global Advanced Balloon Catheter Market Segmentation

The advanced balloon catheter market has been segmented into the product, component, patient age, end-users, application, and region.

By Product Type Outlook (Sales, USD Million, 2017-2030)

• Normal Balloon Catheter
• Cutting and Scoring Balloon Catheter
• Drug-Coated Balloon Catheter
• Stent-Graft Balloon Catheter

By Component Outlook (Sales, USD Million, 2017-2030)

• Over the Wire (OTW) Balloon Catheter
• Rapid Exchange (Rx) Balloon Catheter
• Fixed Wire Balloon Catheter

By Patient Age Outlook (Sales, USD Million, 2017-2030)

• Adult
• Pediatric

By End-Users Outlook (Sales, USD Million, 2017-2030)

• Hospitals and Ambulatory Surgery Centers
• Catheterization Laboratories
• Others (Academic and Research Institutes)

By Application Outlook (Sales, USD Million, 2017-2030)

• Coronary Procedures
  • Balloon angioplasty
  • Transcatheter aortic valve implantation or replacement
  • Drug Delivery
  • Stent Delivery
• Peripheral Procedures
  • Balloon angioplasty
  • Drug Delivery
  • Stent Delivery
• Neurovascular Procedures
• Other Procedures
  • Balloon sinuplasty
  • Balloon kyphoplasty
• Balloon carpal tunnelplasty

By Region Outlook (Sales, USD Million, 2017-2030)

• North America (US, Canada, Mexico)
• South America (Brazil, Argentina, Colombia, Peru, Rest of Latin America)
• Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, the Netherlands, Norway, Sweden, Denmark, Rest of Europe)
• Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, the Philippines, Singapore, Australia & New Zealand, Rest of Asia Pacific)
• The Middle East & Africa (Saudi Arabia, UAE, South Africa, Northern Africa, Rest of MEA)

Adults, by the patient’s age, is estimated to hold the largest market share during the forecast period

Based on the patient's age, the global advanced balloon catheter market can be broadly segmented into adult and pediatric patients. The adult segment generated the highest revenue of 83.9% of the global advanced balloon catheter market in 2021, and it is expected to register a significant CAGR from 2022 to 2030. The balloon catheter treatment for adult patients has witnessed significant advancements since the 1990s. Besides angioplasty, the balloon catheter application has also expanded to orthopedic conditions. For instance, procedures such as kyphoplasty and balloon carpal tunnelplasty were developed in 1988 and 1991, respectively, to treat vertebrae and arms.

Moreover, various specialized balloon catheters have been developed to increase the treatment's effectiveness. For instance, according to the study conducted by the National Center for Biotechnology Information (NCBI), titled “Percutaneous balloon valvuloplasty with Inoue balloon catheter technique for pulmonary valve stenosis in adolescents and adults” in 2017, the usage of Inoue balloon catheter (product of Toray Medical, Inc.) for valvuloplasty procedure resulted into prolonged effectiveness of the treatment. Additionally, there were no complications after the procedure.

Don't miss out on business opportunities in Advanced Balloon Catheter Market. Speak to our research analyst and gain crucial market insights to grow your business.

North America accounts for the largest market share in the advanced balloon catheter market 2021

Based on the regions, the global advanced balloon catheter market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. In 2021, North America accounted for the highest market share of 41.2% in the global advanced balloon catheter market and was anticipated to maintain its dominance throughout the forecast period. The primary drivers for the growth of the advanced balloon catheter market in North America include the increasing prevalence of vascular diseases, rising adoption of minimally invasive surgeries, and rising technological advancement in the balloon catheter landscape.

The U.S. has accounted for the major share in the North America advanced balloon catheter market in 2021. The primary factors propelling the market's growth include the rising prevalence of vascular diseases, the rising prevalence of lifestyle diseases, such as diabetes type-II and hypertension, the launch of various technologically advanced balloon catheters in the country, and a favorable reimbursement landscape.

This research report includes a study on the development and marketing strategies, along with a study on the product portfolios and winning strategies of the leading companies operating in the advanced balloon catheter market. It also consists of the profiles of leading companies such as Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Inc., Koninklijke Philips N.V., Medtronic plc, MicroPort Scientific Corporation, B. Braun Melsungen AG, Becton, Dickinson and Company, Terumo Corporation, Biotronik AG, Cardionovum GmbH, Concept Medical Inc., Cook Group, Hexacath, and OrbusNeich Medical.

Browse complete report: https://www.marketstatsville.com/advanced-balloon-catheter-market

About Market Statsville Group

Market Statsville Group (MSG) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.

MSG has an entire repository of research reports on more than 1,000 niche industries, 3,000 high-growth potentials markets, 5,000 data sets, and more than 12,000 company profiles.

Contact Us:

Market Statsville Group

416, East Standsberry Street, Perkins, Oklahoma 74059, USA

USA: +1-580-205-2707 | +91 702 496 8807

Email: sales@marketstatsville.com

Web: www.marketstatsville.com